Revisiting Diabetes Risk of Olanzapine Versus Aripiprazole in Serious Mental Illness Care
To assess the diabetes risk associated with two frequently used second-generation antipsychotics (SGAs).
Jeannette Tsuei is an assistant policy researcher at RAND and a Ph.D. student in the Technology Applications and Implications stream at the RAND School of Public Policy. Her research focuses on the implementation and governance of machine learning/artificial intelligence to improve public health. She has experience in digital health, informatics, patient safety, mental health, medical simulation technology, user experience, and health equity. Prior to joining RAND, she managed a state-federal grant at the largest health information exchange in California to improve health care data interoperability across Medicaid providers. She also conducted multi-site research on a virtual reality–based therapeutic for pain management, obtaining two National Institute on Drug Abuse Small Business Innovation Research grants. Before focusing on health care, Tsuei worked in a variety of industries on branding, market research, user experience design, and commercialization strategies.
Education
M.A. in anthropology and education, Teachers College, Columbia University; B.A. in anthropology, University of California, Los Angeles
Authored by Jeannette Tsuei
6 Results
